Skip to Content
Merck
  • β-Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria.

β-Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria.

Journal of cellular biochemistry (2018-12-15)
Kang Ding, Yan-Yan Tan, Yang Ding, Yuan Fang, Xu Yang, Jian Fang, Da-Chao Xu, Hui Zhang, Wei Lu, Meng Li, Shi-Cai Huang, Meng-Ling Cai, Yan Song, Yi-Jiang Ding, Su-Min Zhang
ABSTRACT

In this article, we aim to examine the novel effects of β-sitosterol on murine experimental colitis. β-Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF-α, IL-6, and IL-1β in intestinal tissue of mice with experimental colitis in a concentration-dependent manner. β-Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular Salmonella typhimurium. These results showed the multiple effects of β-sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.